IGF1R and ovarian cancer: Finally, we predict that the HGF-induced tumorigenic potential could be due to the upregulation of the Erb-B2 receptor tyrosine kinase3 (ERBB3), which is known to promote the progression and metastasis in ovarian cancer through the IGF1R/STAT2 signaling axis [41].